Myeloid Marker Activators
The Myeloid Marker Activators encompass a diverse array of compounds that indirectly enhance the functional activity of a protein associated with myeloid cells' signaling mechanisms. Compounds such as Plerixafor disrupt the CXCL12-CXCR4 signaling axis, potentially leading to an indirect upregulation of Myeloid Marker activities by altering myeloid lineage dynamics. Lenalidomide, with its capacity to modulate the immune response, may affect signaling pathways that regulate myeloid cell proliferation and differentiation, thereby potentially enhancing Myeloid Marker protein functions.
Other compounds, such as Decitabine, target epigenetic mechanisms, potentially activating genes crucial for myeloid cell maturation, which could result in increased activity of Myeloid Marker proteins. Lithium chloride, on the other hand, may activate the Wnt signaling pathway, influencing myeloid cell proliferation and differentiation, and thus, the activity of Myeloid Marker proteins. These activators, with their varying mechanisms of action, provide a broad spectrum of potentia agents for modulating myeloid cell function and associated immune responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Plerixafor hexa(trifluoroacetic acid salt) | 4069393-93-3 | sc-471854 | 10 mg | $360.00 | ||
Plerixafor is a CXCR4 antagonist that mobilizes hematopoietic stem cells by disrupting the CXCL12-CXCR4 signaling axis. Enhanced mobilization of stem cells may indirectly enhance the functional activity of myeloid marker proteins by altering myeloid lineage dynamics. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Lenalidomide modulates the immune response and affects multiple signaling pathways, including those regulating myeloid cell differentiation and proliferation, potentially enhancing the activity of myeloid marker proteins involved in these processes. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can activate the Wnt signaling pathway by inhibiting GSK-3, which may lead to increased functional activity of proteins associated with myeloid cell proliferation and differentiation. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic acid inhibits farnesyl pyrophosphate synthase, which may affect prenylation of proteins involved in myeloid cell signaling, potentially enhancing the activity of myeloid marker proteins. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
The active form of vitamin D modulates the immune system and can enhance the differentiation of myeloid cells, possibly increasing the activity of myeloid marker proteins through differentiation pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is a glucocorticoid that can influence the proliferation, differentiation, and apoptosis of myeloid cells, which may indirectly affect the functional activity of myeloid marker proteins. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase inhibitor, can lead to the enhanced acetylation of histones, potentially upregulating gene expression and activity of proteins involved in myeloid cell signaling. | ||||||
GM-CSF | 83869-56-1 | sc-280759 | 5 µg | $516.00 | 1 | |
Although GM-CSF is a protein, synthetic analogs or mimetics may be considered chemical compounds. These analogs can stimulate myeloid cell proliferation and differentiation, thereby potentially enhancing the activity of myeloid marker proteins. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib is a tyrosine kinase inhibitor that can affect signaling pathways in myeloid cells and potentially enhance the functional activity of proteins involved in these pathways, including myeloid marker proteins. | ||||||
Amphotericin B | 1397-89-3 | sc-202462 sc-202462A sc-202462B | 100 mg 500 mg 1 g | $70.00 $142.00 $223.00 | 10 | |
As an antifungal that interacts with membrane ergosterol, amphotericin B might influence myeloid cells' membrane properties, indirectly affecting signaling pathways and potentially enhancing myeloid marker protein activity. | ||||||